Exploring the potential anti-COPD ingredients and mechanisms of the Qingfei decoction based on UHPLC-HRMS, network pharmacology and transcriptomic analysis

This publication has 18 references indexed in Scilit:

• Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition)
  Respiratory Investigation, 2023
• Impact of pharmacological and non-pharmacological interventions on mortality in chronic obstructive pulmonary disease (COPD) patients
  Respiratory Medicine and Research, 2023
• Network pharmacology-based identification of bioavailable anti-inflammatory agents from Psoralea corylifolia L. in an experimental colitis model
  Journal of Ethnopharmacology, 2023
• Seeds of Ginkgo biloba L. inhibit oxidative stress and inflammation induced by cigarette smoke in COPD rats through the Nrf2 pathway
  Journal of Ethnopharmacology, 2022
• Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification
  Journal of Ethnopharmacology, 2022
• An integrated network pharmacology and RNA-Seq approach for exploring the preventive effect of Lonicerae japonicae flos on LPS-induced acute lung injury
  Journal of Ethnopharmacology, 2021
• Rapid identification and analysis of the active components of traditional Chinese medicine Xiaoxuming decoction for ischemic stroke treatment by integrating UPLC-Q-TOF/MS and RRLC-QTRAP MSn method
  Journal of Chromatography B, 2019
• T2 Biologics for Chronic Obstructive Pulmonary Disease
  The Journal of Allergy and Clinical Immunology: In Practice, 2019
• Chronic obstructive pulmonary disease
  Nature Reviews Disease Primers, 2015
• IL-17 family: Cytokines, receptors and signaling
  Cytokine, 2013